India’s Bharat Biotech will be producing part of the world’s only malaria vaccine that has been developed by Pharma major GSK, and was recently approved by WHO (World Health Organisation). However, it may take a couple of years before the vaccine is launched in the market for use. In January, this year, Hyderabad-based vaccine major announced that it entered a product transfer partnership with the pharma major GSK for its malaria vaccine, RTS, S/AS01E1.As part of this partnership, GSK would transfer RTS manufacturing technology to Bharat Biotech to produce the S antigen component of the malaria vaccine, and the license on all rights pertaining to it. GSK will retain the production of the adjuvant of the vaccine (AS01E) and will supply it to Bharat Biotech.
United States
One dead, two arrested after shooting behind Fort Worth shopping center
FORTWORTH, TX(TIP): Fort Worth police arrested two shooting suspects after they ran and attempted to hide inside Hulen Mall. The shooting happened behind a shopping center at Hulen Street and South Drive, but the two […]
Asia
Lankan fuel pumps may go dry by April end; India’s USD 500 million credit line exhausting rapidly
Colombo (TIP): Sri Lanka may run out of diesel by the end of this month with the USD 500 million line of credit extended by India for fuel purchase exhausting fast amidst the unprecedented shortage […]
World
Vladimir Putin, before election, unveils new nuclear weapons to counter West
MOSCOW (TIP): President Vladimir Putin unveiled an array of new nuclear weapons on March 1, in one of his most bellicose speeches in years, saying they could hit almost any point in the world and not be intercepted. Speaking […]
Be the first to comment